95 results on '"Barber, Daniel L."'
Search Results
2. BACH1 promotes tissue necrosis and Mycobacterium tuberculosis susceptibility
- Author
-
Amaral, Eduardo P., Namasivayam, Sivaranjani, Queiroz, Artur T. L., Fukutani, Eduardo, Hilligan, Kerry L., Aberman, Kate, Fisher, Logan, Bomfim, Caio Cesar B., Kauffman, Keith, Buchanan, Jay, Santuo, Leslie, Gazzinelli-Guimaraes, Pedro Henrique, Costa, Diego L., Teixeira, Mariane Araujo, Barreto-Duarte, Beatriz, Rocha, Clarissa Gurgel, Santana, Monique Freire, Cordeiro-Santos, Marcelo, Barber, Daniel L., Wilkinson, Robert J., Kramnik, Igor, Igarashi, Kazuhiko, Scriba, Thomas, Mayer-Barber, Katrin D., Andrade, Bruno B., and Sher, Alan
- Published
- 2024
- Full Text
- View/download PDF
3. Rapid pathogen-specific recruitment of immune effector cells in the skin by secreted toxins
- Author
-
Nguyen, Thuan H., Cheung, Gordon Y. C., Rigby, Kevin M., Kamenyeva, Olena, Kabat, Juraj, Sturdevant, Daniel E., Villaruz, Amer E., Liu, Ryan, Piewngam, Pipat, Porter, Adeline R., Firdous, Saba, Chiou, Janice, Park, Matthew D., Hunt, Rachelle L., Almufarriji, Fawaz M. F., Tan, Vee Y., Asiamah, Titus K., McCausland, Joshua W., Fisher, Emilie L., Yeh, Anthony J., Bae, Justin S., Kobayashi, Scott D., Wang, Ji Ming, Barber, Daniel L., DeLeo, Frank R., and Otto, Michael
- Published
- 2022
- Full Text
- View/download PDF
4. Mycobacterium tuberculosis-specific CD4 T cells expressing CD153 inversely associate with bacterial load and disease severity in human tuberculosis
- Author
-
Du Bruyn, Elsa, Ruzive, Sheena, Lindestam Arlehamn, Cecilia S., Sette, Alessandro, Sher, Alan, Barber, Daniel L., Wilkinson, Robert J., and Riou, Catherine
- Published
- 2021
- Full Text
- View/download PDF
5. Exacerbation of CMV and Nontuberculous Mycobacterial Infections Following PD-1 Blockade for HIV-Associated Kaposi Sarcoma.
- Author
-
Anidi, Ifeanyichukwu U, Sakai, Shunsuke, Brooks, Kelsie, Fling, Steven P, Wagner, Michael J, Lurain, Kathryn, Arlehamn, Cecilia S Lindestam, Sette, Alessandro, Knox, Kenneth S, Brenchley, Jason M, Uldrick, Thomas S, Sharon, Elad, and Barber, Daniel L
- Subjects
MYCOBACTERIAL diseases ,KAPOSI'S sarcoma ,PROGRAMMED cell death 1 receptors ,LYMPHADENITIS ,T cells ,DISEASE exacerbation - Abstract
Blockade of the co-inhibitory receptor PD-1 enhances antitumor responses by boosting the function of antigen-specific T cells. Although rare, PD-1 blockade in patients with cancer can lead to exacerbation of infection-associated pathology. Here, we detail the case of a 38-year-old man who was enrolled in a clinical trial for assessment of the safety and activity of anti–PD-1 therapy for Kaposi sarcoma in people with HIV well-controlled on antiretroviral therapy. Less than a week after receiving the first dose of anti–PD-1 antibody (pembrolizumab), he presented with severe abdominal pain associated with sudden exacerbations of preexisting cytomegalovirus (CMV) enteritis and nontuberculous mycobacterial mesenteric lymphadenitis. Plasma biomarkers of gastrointestinal tract damage were highly elevated compared with healthy controls, consistent with HIV-associated loss of gut epithelial barrier integrity. Moreover, CMV-specific CD8 T cells expressed high levels of PD-1, and 7 days following PD-1 blockade, there was an increase in the frequency of activated CD38
+ Ki67+ CMV-specific CD8 T cells. This case highlights the potential for PD-1 blockade to drive rapid exacerbations of inflammatory symptoms when administered to individuals harboring multiple unresolved infections. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
6. MAIT cell-directed therapy of Mycobacterium tuberculosis infection
- Author
-
Sakai, Shunsuke, Kauffman, Keith D., Oh, Sangmi, Nelson, Christine E., Barry, III, Clifton E., and Barber, Daniel L.
- Published
- 2021
- Full Text
- View/download PDF
7. Migration-induced cell shattering due to DOCK8 deficiency causes a type 2–biased helper T cell response
- Author
-
Schneider, Caitlin, Shen, Connie, Gopal, Angelica A., Douglas, Todd, Forestell, Benjamin, Kauffman, Keith D., Rogers, Dakota, Artusa, Patricio, Zhang, Qian, Jing, Huie, Freeman, Alexandra F., Barber, Daniel L., King, Irah L., Saleh, Maya, Wiseman, Paul W., Su, Helen C., and Mandl, Judith N.
- Published
- 2020
- Full Text
- View/download PDF
8. Host resistance to pulmonary Mycobacterium tuberculosis infection requires CD153 expression
- Author
-
Sallin, Michelle A., Kauffman, Keith D., Riou, Catherine, Du Bruyn, Elsa, Foreman, Taylor W., Sakai, Shunsuke, Hoft, Stella G., Myers, Timothy G., Gardina, Paul J., Sher, Alan, Moore, Rashida, Wilder-Kofie, Temeri, Moore, Ian N., Sette, Alessandro, Lindestam Arlehamn, Cecilia S., Wilkinson, Robert J., and Barber, Daniel L.
- Published
- 2018
- Full Text
- View/download PDF
9. Antigen-Independent Memory CD8 T Cells Do Not Develop during Chronic Viral Infection
- Author
-
Wherry, E. John, Barber, Daniel L., Kaech, Susan M., Blattman, Joseph N., Ahmed, Rafi, and Marrack, Philippa
- Published
- 2004
10. Lethal CD4 T Cell Responses Induced by Vaccination Against Staphylococcus aureus Bacteremia
- Author
-
Karauzum, Hatice, Haudenschild, Christian C., Moore, Ian N., Mahmoudieh, Mahta, Barber, Daniel L., and Datta, Sandip K.
- Published
- 2017
11. Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
- Author
-
Kamphorst, Alice O., Wieland, Andreas, Nasti, Tahseen, Yang, Shu, Zhang, Ruan, Barber, Daniel L., Konieczny, Bogumila T., Daugherty, Candace Z., Koenig, Lydia, Yu, Ke, Sica, Gabriel L., Sharpe, Arlene H., Freeman, Gordon J., Blazar, Bruce R., Turka, Laurence A., Owonikoko, Taofeek K., Pillai, Rathi N., Ramalingam, Suresh S., Araki, Koichi, and Ahmed, Rafi
- Published
- 2017
12. Severe Paradoxical Reaction During Treatment of Disseminated Tuberculosis in a Patient With Neutralizing Anti-IFNγ Autoantibodies
- Author
-
Xie, Yingda L., Rosen, Lindsey B., Sereti, Irini, Barber, Daniel L., Chen, Ray Y., Hsu, Denise C., Qasba, S. Sonia, Zerbe, Christa S., Holland, Steven M., and Browne, Sarah K.
- Published
- 2016
13. Blood and Site of Disease Inflammatory Profiles Differ in Patients With Pericardial Tuberculosis and Human Immunodeficiency Virus Type 1.
- Author
-
Mutavhatsindi, Hygon, Bruyn, Elsa Du, Ruzive, Sheena, Howlett, Patrick, Cerrone, Maddalena, Sher, Alan, Mayer-Barber, Katrin D, Barber, Daniel L, Ntsekhe, Mpiko, Wilkinson, Robert J, and Riou, Catherine
- Abstract
Background To better understand the pathogenesis of pericardial tuberculosis (PCTB), we sought to characterize the systemic inflammatory profile in people with human immunodeficiency virus type 1 (HIV-1) with latent TB infection (LTBI), pulmonary TB (PTB), or PCTB. Methods Using Luminex, we measured the concentration of 39 analytes in pericardial fluid (PCF) and paired plasma from 18 PCTB participants, and plasma from 16 LTBI and 20 PTB participants. Follow-up plasma samples were also obtained from PTB and PCTB participants. HLA-DR expression on Mycobacterium tuberculosis –specific CD4 T cells was measured in baseline samples using flow cytometry. Results Assessment of the overall systemic inflammatory profile by principal component analysis showed that the inflammatory profile of active TB participants was distinct from the LTBI group, while PTB patients could not be distinguished from those with PCTB. When comparing the inflammatory profile between PCF and paired blood, we found that the concentrations of most analytes (25/39) were elevated at site of disease. However, the inflammatory profile in PCF partially mirrored inflammatory events in the blood. After TB treatment completion, the overall plasma inflammatory profile reverted to that observed in the LTBI group. Lastly, HLA-DR expression showed the best performance for TB diagnosis compared to previously described biosignatures built from soluble markers. Conclusions Our results show that the inflammatory profile in blood was comparable between PTB and PCTB. However, at the site of infection (PCF), inflammation was significantly elevated compared to blood. Additionally, our data emphasize the potential role of HLA-DR expression as a biomarker for TB diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
14. Induction of Inhibitory Receptors on T Cells During Plasmodium vivax Malaria Impairs Cytokine Production
- Author
-
Costa, Pedro A. C., Leoratti, Fabiana M. S., Figueiredo, Maria M., Tada, Mauro S., Pereira, Dhelio B., Junqueira, Caroline, Soares, Irene S., Barber, Daniel L., Gazzinelli, Ricardo T., and Antonelli, Lis R. V.
- Published
- 2015
15. Co-infection of mice with SARS-CoV-2 and Mycobacterium tuberculosis limits early viral replication but does not affect mycobacterial loads.
- Author
-
Baker, Paul J., Amaral, Eduardo P., Castro, Ehydel, Bohrer, Andrea C., Torres-Juárez, Flor, Jordan, Cassandra M., Nelson, Christine E., Barber, Daniel L., Johnson, Reed F., Hilligan, Kerry L., and Mayer-Barber, Katrin D.
- Subjects
MYCOBACTERIUM tuberculosis ,VIRAL replication ,VIRUS diseases ,SARS-CoV-2 ,COVID-19 pandemic - Abstract
Viral co-infections have been implicated in worsening tuberculosis (TB) and during the COVID-19 pandemic, the global rate of TB-related deaths has increased for the first time in over a decade. We and others have previously shown that a resolved prior or concurrent influenza A virus infection in Mycobacterium tuberculosis (Mtb)-infected mice resulted in increased pulmonary bacterial burden, partly through type I interferon (IFN-I)-dependent mechanisms. Here we investigated whether SARS-CoV-2 (SCV2) co-infection could also negatively affect bacterial control of Mtb. Importantly, we found that K18-hACE2 transgenic mice infected with SCV2 one month before, or months after aerosol Mtb exposure did not display exacerbated Mtb infection-associated pathology, weight loss, nor did they have increased pulmonary bacterial loads. However, pre-existing Mtb infection at the time of exposure to the ancestral SCV2 strain in infected K18-hACE2 transgenic mice or the beta variant (B.1.351) in WT C57Bl/6 mice significantly limited early SCV2 replication in the lung. Mtb-driven protection against SCV2 increased with higher bacterial doses and did not require IFN-I, TLR2 or TLR9 signaling. These data suggest that SCV2 co-infection does not exacerbate Mtb infection in mice, but rather the inflammatory response generated by Mtb infection in the lungs at the time of SCV2 exposure restricts viral replication. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
16. Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection
- Author
-
Aubert, Rachael D., Kamphorst, Alice O., Sarkar, Surojit, Vezys, Vaiva, Ha, Sang-Jun, Barber, Daniel L., Ye, Lilin, Sharpe, Arlene H., Freeman, gordon J., and Ahmed, Rafi
- Published
- 2011
17. Estimation of the Rate of Killing by Cytotoxic T Lymphocytes in vivo
- Author
-
Regoes, Roland R., Barber, Daniel L., Ahmed, Rafi, and Antia, Rustom
- Published
- 2007
- Full Text
- View/download PDF
18. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
- Author
-
Mayer-Barber, Katrin D., Andrade, Bruno B., Oland, Sandra D., Amaral, Eduardo P., Barber, Daniel L., Gonzales, Jacqueline, Derrick, Steven C., Shi, Ruiru, Kumar, Nathella Pavan, Wei, Wang, Yuan, Xing, Zhang, Guolong, Cai, Ying, Babu, Subash, Catalfamo, Marta, Salazar, Andres M., Via, Laura E., Barry, III, Clifton E., and Sher, Alan
- Subjects
Interferon -- Dosage and administration -- Research ,Tuberculosis -- Research -- Prevention -- Risk factors -- Drug therapy -- Patient outcomes ,Biological response modifiers -- Research ,Interleukins -- Research ,Environmental issues ,Science and technology ,Zoology and wildlife conservation - Abstract
Tuberculosis remains second only to HIV/AIDS as the leading cause of mortality worldwide due to a single infectious agent (1). Despite chemotherapy, the global tuberculosis epidemic has intensified because of [...]
- Published
- 2014
19. Intravascular staining for discrimination of vascular and tissue leukocytes
- Author
-
Anderson, Kristin G, Mayer-Barber, Katrin, Sung, Heungsup, Beura, Lalit, James, Britnie R, Taylor, Justin J, Qunaj, Lindor, Griffith, Thomas S, Vezys, Vaiva, Barber, Daniel L, and Masopust, David
- Published
- 2014
- Full Text
- View/download PDF
20. Phenotypic Profile of Mycobacterium tuberculosis-Specific CD4 T-Cell Responses in People With Advanced Human Immunodeficiency Virus Who Develop Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
- Author
-
Moseki, Raymond M, Barber, Daniel L, Bruyn, Elsa Du, Shey, Muki, Plas, Helen Van der, Wilkinson, Robert J, Meintjes, Graeme, and Riou, Catherine
- Subjects
- *
IMMUNE reconstitution inflammatory syndrome , *HIV , *CD4 antigen , *T cells , *MYCOBACTERIUM , *MYCOBACTERIUM avium - Abstract
Background Tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) is a frequent complication of cotreatment for TB and human immunodeficiency virus (HIV)-1. We characterized Mycobacterium tuberculosis (Mtb)-specific CD4 T-cell phenotype and transcription factor profile associated with the development of TB-IRIS. Methods We examined the role of CD4 T-cell transcription factors in a murine model of mycobacterial IRIS. In humans, we used a longitudinal study design to compare the magnitude of antiretroviral therapy, activation, transcription factor profile, and cytotoxic potential of Mtb-specific CD4 T cells between TB-IRIS (n = 25) and appropriate non-IRIS control patients (n = 18) using flow cytometry. Results In the murine model, CD4 T-cell expression of Eomesodermin (Eomes), but not Tbet, was associated with experimentally induced IRIS. In patients, TB-IRIS onset was associated with the expansion of Mtb-specific IFNγ+CD4 T cells (P =.039). Patients with TB-IRIS had higher HLA-DR expression (P =.016), but no differences in the expression of T-bet or Eomes were observed. At TB-IRIS onset, Eomes+Tbet+Mtb-specific IFNγ+CD4+ T cells showed higher expression of granzyme B in patients with TB-IRIS (P =.026). Conclusions Although the murine model of Mycobacterium avium complex-IRIS suggests that Eomes+CD4 T cells underly IRIS, TB-IRIS was not associated with Eomes expression in patients. Mycobacterium tuberculosis -specific IFNγ+CD4 T-cell responses in TB-IRIS patients are differentiated, highly activated, and potentially cytotoxic. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
21. Comparison of the frequency and phenotypic profile of Mycobacterium tuberculosisspecific CD4 T cells between the site of disease and blood in pericardial tuberculosis.
- Author
-
Du Bruyn, Elsa, Ruzive, Sheena, Howlett, Patrick, Jacobs, Ashley J., Arlehamn, Cecilia S. Lindestam, Sette, Alessandro, Sher, Alan, Mayer-Barber, Katrin D., Barber, Daniel L., Mayosi, Bongani, Ntsekhe, Mpiko, Wilkinson, Robert J., and Riou, Catherine
- Subjects
T cells ,BLOOD diseases ,CD4 antigen ,PERICARDIUM diseases ,MYCOBACTERIUM ,MYCOBACTERIUM avium paratuberculosis - Abstract
Studies of the immune response at the site of disease in extra-pulmonary tuberculosis (EPTB) disease are scarce. In this study, we compared the cellular profile of Mycobacterium tuberculosis (Mtb)-specific T cells in pericardial fluid and peripheral blood in patients with pericardial TB (PCTB). Whole blood and pericardial fluid (PCF) samples were collected at the time of diagnostic sampling, with repeat blood sampling after completion of anti-tubercular treatment (ATT) in 16 PCTB patients, most of them being HIV-1 infected (n=14). These samples were stimulated ex vivo and the phenotypic and functional cellular profile of PCF and blood was assessed by flow cytometry. We found that lymphocytes were the predominant cell type in PCF in PCTB, with a preferential influx of CD4 T cells. The frequencies of TNF-a producing Mtb-specific granulocytes and Mtb-specific CD4 T cells were significantly higher in PCF compared to blood. Mtb-specific CD4 T cells in PCF exhibited a distinct phenotype compared to those in blood, with greater GrB expression and lower CD27 and KLRG1 expression. We observed no difference in the production IFNg, TNF or IL-2 by Mtb-specific CD4 T cells between the two compartments, but MIP-1b production was lower in the PCF T cells. Bacterial loads were not associated with alterations in the phenotype or function of Mtbspecific CD4 T cells. Upon ATT completion, HLA-DR, Ki-67 and GrB expression was significantly decreased, and relative IL-2 production was increased in peripheral Mtb-specific CD4 T cells. Overall, using an ex vivo assay to compare the immune response towards Mtb in PCF and in blood, we identified significant difference in the phenotypic profile of Mtb-specific CD4 T response between these two compartments. Moreover, we show that the activation profile of peripheral Mtb-specific CD4 T cells could be used to monitor treatment response in PCTB. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
22. Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome
- Author
-
Antonelli, Lis R.V., Mahnke, Yolanda, Hodge, Jessica N., Porter, Brian O., Barber, Daniel L., DerSimonian, Rebecca, Greenwald, Jamieson H., Roby, Gregg, Mican, JoAnn, Sher, Alan, Roederer, Mario, and Sereti, Irini
- Published
- 2010
- Full Text
- View/download PDF
23. Th1-driven immune reconstitution disease in Mycobacterium avium–infected mice
- Author
-
Barber, Daniel L., Mayer-Barber, Katrin D., Antonelli, Lis R.V., Wilson, Mark S., White, Sandra, Caspar, Patricia, Hieny, Sara, Sereti, Irini, and Sher, Alan
- Published
- 2010
- Full Text
- View/download PDF
24. T CELL VACCINES: Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infection
- Author
-
Penaloza-MacMaster, Pablo, Barber, Daniel L., Wherry, John E., Provine, Nicholas M., Teigler, Jeffrey E., Parenteau, Lily, Blackmore, Stephen, Borducchi, Erica N., Larocca, Rafael A., Yates, Kathleen B., Shen, Hao, Haining, Nicholas W., Sommerstein, Rami, Pinschewer, Daniel D., Ahmed, Rafi, and Barouch, Dan H.
- Published
- 2015
- Full Text
- View/download PDF
25. Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection
- Author
-
Li, Qingsheng, Skinner, Pamela J., Ha, Sang-Jun, Duan, Lijie, Mattila, Teresa L., Hage, Aaron, White, Cara, Barber, Daniel L., O'Mara, Leigh, Southern, Peter J., Reilly, Cavan S., Carlis, John V., Miller, Christopher J., Ahmed, Rafi, and Haase, Ashley T.
- Subjects
Virus diseases -- Patient outcomes ,Immune response -- Research ,Science and technology - Abstract
In the early stages of viral infection, outcomes depend on a race between expansion of infection and the immune response generated to contain it. We combined in situ tetramer staining with in situ hybridization to visualize, map, and quantify relationships between immune effector cells and their targets in tissues. In simian immunodeficiency virus infections in macaques and lymphocytic choriomeningitis virus infections in mice, the magnitude and timing of the establishment of an excess of effector ceils versus targets were found to correlate with the extent of control and the infection outcome (i.e., control and clearance versus partial or poor control and persistent infection). This method highlights the importance of the location, timing, and magnitude of the immune response needed for a vaccine to be effective against agents of persistent infection, such as HIV-1.
- Published
- 2009
26. Innate and Adaptive Interferons Suppress IL-1α and IL-1β Production by Distinct Pulmonary Myeloid Subsets during Mycobacterium tuberculosis Infection
- Author
-
Mayer-Barber, Katrin D., Andrade, Bruno B., Barber, Daniel L., Hieny, Sara, Feng, Carl G., Caspar, Patricia, Oland, Sandy, Gordon, Siamon, and Sher, Alan
- Published
- 2011
- Full Text
- View/download PDF
27. Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
- Author
-
Wherry, John E., Ha, Sang-Jun, Kaech, Susan M., Haining, Nicholas W., Sarkar, Surojit, Kalia, Vandana, Subramaniam, Shruti, Blattman, Joseph N., Barber, Daniel L., and Ahmed, Rafi
- Published
- 2007
- Full Text
- View/download PDF
28. Restoring function in exhausted CD8 T cells during chronic viral infection
- Author
-
Barber, Daniel L., Wherry, E. John, Masopust, David, Zhu, Baogong, Allison, James P., Sharpe, Arlene H., Freeman, Gordon J., and Ahmed, Rafi
- Published
- 2006
29. Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques.
- Author
-
Venkatasubramaniam, Arundhathi, Liao, Grant, Cho, Eunice, Adhikari, Rajan P., Kort, Tom, Holtsberg, Frederick W., Elsass, Karen E., Kobs, Dean J., Rudge, Thomas L., Kauffman, Keith D., Lora, Nickiana E., Barber, Daniel L., Aman, M. Javad, and Karauzum, Hatice
- Subjects
RHESUS monkeys ,STAPHYLOCOCCUS aureus ,EXOTOXIN ,HUMORAL immunity ,VACCINES ,T cells ,ACTINOBACILLUS actinomycetemcomitans - Abstract
Staphylococcus aureus is a leading cause of significant morbidity and mortality and an enormous economic burden to public health worldwide. Infections caused by methicillin-resistant S. aureus (MRSA) pose a major threat as MRSA strains are becoming increasingly prevalent and multi-drug resistant. To this date, vaccines targeting surface-bound antigens demonstrated promising results in preclinical testing but have failed in clinical trials. S. aureus pathogenesis is in large part driven by immune destructive and immune modulating toxins and thus represent promising vaccine targets. Hence, the objective of this study was to evaluate the safety and immunogenicity of a staphylococcal 4-component vaccine targeting secreted bi-component pore-forming toxins (BCPFTs) and superantigens (SAgs) in non-human primates (NHPs). The 4-component vaccine proved to be safe, even when repeated vaccinations were given at a dose that is 5 to 10- fold higher than the proposed human dose. Vaccinated rhesus macaques did not exhibit clinical signs, weight loss, or changes in hematology or serum chemistry parameters related to the administration of the vaccine. No acute, vaccine-related elevation of serum cytokine levels was observed after vaccine administration, confirming the toxoid components lacked superantigenicity. Immunized animals demonstrated high level of toxin-specific total and neutralizing antibodies toward target antigens of the 4-component vaccine as well as cross-neutralizing activity toward staphylococcal BCPFTs and SAgs that are not direct targets of the vaccine. Cross-neutralization was also observed toward the heterologous streptococcal pyogenic exotoxin B. Ex vivo stimulation of PBMCs with individual vaccine components demonstrated an overall increase in several T cell cytokines measured in supernatants. Immunophenotyping of CD4 T cells ex vivo showed an increase in Ag-specific polyfunctional CD4 T cells in response to antigen stimulation. Taken together, we demonstrate that the 4-component vaccine is well-tolerated and immunogenic in NHPs generating both humoral and cellular immune responses. Targeting secreted toxin antigens could be the next-generation vaccine approach for staphylococcal vaccines if also proven to provide efficacy in humans. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
30. Disease extent and anti‐tubercular treatment response correlates with Mycobacterium tuberculosis‐specific CD4 T‐cell phenotype regardless of HIV‐1 status.
- Author
-
Riou, Catherine, Du Bruyn, Elsa, Ruzive, Sheena, Goliath, Rene T, Lindestam Arlehamn, Cecilia S, Sette, Alessandro, Sher, Alan, Barber, Daniel L, and Wilkinson, Robert J
- Subjects
TUBERCULOSIS ,MYCOBACTERIUM ,MYCOBACTERIUM tuberculosis ,SPINAL tuberculosis ,PRINCIPAL components analysis ,T cells - Abstract
Objectives: The development of non‐sputum‐based assays for tuberculosis (TB) diagnosis and treatment monitoring is a key priority. Recent data indicate that whole blood‐based assays to assess the phenotype of Mycobacterium tuberculosis (Mtb)‐specific CD4 T cells hold promise for this purpose and require further investigation in well‐characterised TB cohorts. In this study, we investigated the relationship between the phenotypic signature of Mtb‐specific CD4 responses, TB disease extent and treatment response. Methods: Using flow cytometry, we measured the expression of phenotypic and functional markers (HLA‐DR, CD27, CD153, KLRG1, IL‐2, MIP‐1β, TNF‐α and IFN‐γ) on Mtb‐specific CD4 T‐cells in whole blood from 161 participants of varying TB and HIV status. TB disease extent was graded as a continuum using the Xpertct value, C‐reactive protein, Timika radiographic score and monocyte/lymphocyte ratio. Results: The phenotypic profile of Mtb‐specific CD4 T cells pre‐anti‐tubercular treatment (ATT) strongly correlated with disease extent, irrespective of HIV status. ATT associated with major changes in the phenotype of Mtb‐specific CD4 T cells, with decreased expression of HLA‐DR and increased CD27 and CD153 expression. Principal component analysis showed an almost complete separation between latent TB infection (LTBI) and active TB (aTB) pre‐ATT groups, whereas the profile of the aTB post‐ATT group overlapped with the LTBI group. However, in patients experiencing treatment failure or relapse, no significant changes were observed in Mtb‐specific CD4 T‐cell phenotype pre‐ and post‐ATT. Conclusion: Whole blood‐based assays of Mtb‐specific CD4 T‐cell activation and maturation markers can be used as non‐sputum‐based biomarkers of disease extent and treatment monitoring in TB, regardless of HIV‐1 status. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
31. Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research.
- Author
-
Daniel-Wayman, Shelby, Abate, Getahun, Barber, Daniel L, Bermudez, Luiz E, Coler, Rhea N, Cynamon, Michael H, Daley, Charles L, Davidson, Rebecca M, Dick, Thomas, Floto, R Andres, Henkle, Emily, Holland, Steven M, Jackson, Mary, Lee, Richard E, Nuermberger, Eric L, Olivier, Kenneth N, Ordway, Diane J, Prevots, D Rebecca, Sacchettini, James C, and Salfinger, Max
- Published
- 2019
- Full Text
- View/download PDF
32. Th1 Differentiation Drives the Accumulation of Intravascular, Non-protective CD4 T Cells during Tuberculosis.
- Author
-
Sallin, Michelle A., Sakai, Shunsuke, Kauffman, Keith D., Young, Howard A., Jinfang Zhu, and Barber, Daniel L.
- Abstract
Recent data indicate that the differentiation state of Th1 cells determines their protective capacity against tuberculosis. Therefore, we examined the role of Th1-polarizing factors in the generation of protective and non-protective subsets of Mtb-specific Th1 cells. We find that IL-12/23p40 promotes Th1 cell expansion and maturation beyond the CD73
+ CXCR3+ T-betdim stage, and T-bet prevents deviation of Th1 cells into Th17 cells. Nevertheless, IL- 12/23p40 and T-bet are also essential for the production of a prominent subset of intravascular CX3CR1+ KLRG1+ Th1 cells that persists poorly and can neither migrate into the lung parenchyma nor control Mtb growth. Furthermore, T-bet suppresses development of CD69+ CD103+ tissue resident phenotype effectors in lung. In contrast, Th1-cell-derived IFN-γ inhibits the accumulation of intravascular CX3CR1+ KLRG1+ Th1 cells. Thus, although IL-12 and T-bet are essential host survival factors, they simultaneously oppose lung CD4 T cell responses at several levels, demonstrating the dual nature of Th1 polarization in tuberculosis. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
33. CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease.
- Author
-
Sakai, Shunsuke, Kauffman, Keith D., Sallin, Michelle A., Sharpe, Arlene H., Young, Howard A., Ganusov, Vitaly V., and Barber, Daniel L.
- Subjects
CD4 antigen ,MYCOBACTERIUM tuberculosis ,T cells ,PROGRAMMED cell death 1 receptors ,INTERFERONS - Abstract
IFN-γ–producing CD4 T cells are required for protection against Mycobacterium tuberculosis (Mtb) infection, but the extent to which IFN-γ contributes to overall CD4 T cell-mediated protection remains unclear. Furthermore, it is not known if increasing IFN-γ production by CD4 T cells is desirable in Mtb infection. Here we show that IFN-γ accounts for only ~30% of CD4 T cell-dependent cumulative bacterial control in the lungs over the first six weeks of infection, but >80% of control in the spleen. Moreover, increasing the IFN-γ–producing capacity of CD4 T cells by ~2 fold exacerbates lung infection and leads to the early death of the host, despite enhancing control in the spleen. In addition, we show that the inhibitory receptor PD-1 facilitates host resistance to Mtb by preventing the detrimental over-production of IFN-γ by CD4 T cells. Specifically, PD-1 suppressed the parenchymal accumulation of and pathogenic IFN-γ production by the CXCR3
+ KLRG1- CX3CR1- subset of lung-homing CD4 T cells that otherwise mediates control of Mtb infection. Therefore, the primary role for T cell-derived IFN-γ in Mtb infection is at extra-pulmonary sites, and the host-protective subset of CD4 T cells requires negative regulation of IFN-γ production by PD-1 to prevent lethal immune-mediated pathology. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
34. Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis.
- Author
-
Sionov, Edward, Mayer-Barber, Katrin D., Chang, Yun C., Kauffman, Keith D., Eckhaus, Michael A., Salazar, Andres M., Barber, Daniel L., and Kwon-Chung, Kyung J.
- Subjects
TYPE I interferons ,CRYPTOCOCCUS neoformans ,IMMUNE response ,CELLULAR immunity ,LABORATORY mice - Abstract
Cryptococcus neoformans is the most common cause of fungal meningoencephalitis in AIDS patients. Depletion of CD4 cells, such as occurs during advanced AIDS, is known to be a critical risk factor for developing cryptococcosis. However, the role of HIV-induced innate inflammation in susceptibility to cryptococcosis has not been evaluated. Thus, we sought to determine the role of Type I IFN induction in host defense against cryptococci by treatment of C. neoformans (H99) infected mice with poly-ICLC (pICLC), a dsRNA virus mimic. Unexpectedly, pICLC treatment greatly extended survival of infected mice and reduced fungal burdens in the brain. Protection from cryptococcosis by pICLC-induced Type I IFN was mediated by MDA5 rather than TLR3. PICLC treatment induced a large, rapid and sustained influx of neutrophils and Ly6C
high monocytes into the lung while suppressing the development of eosinophilia. The pICLC-mediated protection against H99 was CD4 T cell dependent and analysis of CD4 T cell polyfunctionality showed a reduction in IL-5 producing CD4 T cells, marginal increases in Th1 cells and dramatic increases in RORγt+ Th17 cells in pICLC treated mice. Moreover, the protective effect of pICLC against H99 was diminished in IFNγ KO mice and by IL-17A neutralization with blocking mAbs. Furthermore, pICLC treatment also significantly extended survival of C. gattii infected mice with reduced fungal loads in the lungs. These data demonstrate that induction of type I IFN dramatically improves host resistance against the etiologic agents of cryptococcosis by beneficial alterations in both innate and adaptive immune responses. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
35. Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infection.
- Author
-
Penaloza-MacMaster, Pablo, Barber, Daniel L., Wherry, E. John, Provine, Nicholas M., Teigler, Jeffrey E., Parenteau, Lily, Blackmore, Stephen, Borducchi, Erica N., Larocca, Rafael A., Yates, Kathleen B., Hao Shen, Haining, W. Nicholas, Sommerstein, Rami, Pinschewer, Daniel D., Ahmed, Rafi, and Barouch, Dan H.
- Subjects
- *
IMMUNOLOGY , *LYMPHOCYTIC choriomeningitis , *EFFECT of drugs on T cells , *CD4 antigen , *NATURAL immunity , *IMMUNOPATHOLOGY , *IMMUNE response , *IMMUNOLOGY of inflammation , *VACCINATION - Abstract
CD4 T cells promote innate and adaptive immune responses, but how vaccine-elicited CD4 T cells contribute to immune protection remains unclear. We evaluated whether induction of virus-specific CD4 T cells by vaccination would protect mice against infection with chronic lymphocytic choriomeningitis virus (LCMV). Immunization with vaccines that selectively induced CD4 T cell responses resulted in catastrophic inflammation and mortality after challenge with a persistent strain of LCMV. Immunopathology required antigen-specific CD4 T cells and was associated with a cytokine storm, generalized inflammation, and multi-organ system failure. Virus-specific CD8 T cells or antibodies abrogated the pathology. These data demonstrate that vaccine-elicited CD4 T cells in the absence of effective antiviral immune responses can trigger lethal immunopathology. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
36. PD-L1 up-regulation restrains Th17 cell differentiation in STAT3 loss- and STAT1 gain-of-function patients
- Author
-
Zhang, Yuan, Ma, Chi A., Lawrence, Monica G., Break, Timothy J., O’Connell, Michael P., Lyons, Jonathan J., López, Diego B., Barber, John S., Zhao, Yongge, Barber, Daniel L., Freeman, Alexandra F., Holland, Steven M., Lionakis, Michail S., and Milner, Joshua D.
- Subjects
Brief Definitive Report - Abstract
Patients with hypomorphic mutations in STAT3 and patients with hypermorphic mutations in STAT1 share several clinical and cellular phenotypes suggesting overlapping pathophysiologic mechanisms. We, therefore, examined cytokine signaling and CD4+ T cell differentiation in these cohorts to characterize common pathways. As expected, differentiation of Th17 cells was impaired in both cohorts. We found that STAT1 was hyperphosphorylated in response to cytokine stimulation in both cohorts and that STAT1-dependent PD-L1 up-regulation—known to inhibit Th17 differentiation in mouse models—was markedly enhanced as well. Overexpression of SOCS3 strongly inhibited phosphorylation of STAT1 and PD-L1 up-regulation, suggesting that diminished SOCS3 expression may lead to the observed effects. Defects in Th17 differentiation could be partially overcome in vitro via PD-L1 inhibition and in a mouse model of STAT3 loss-of-function by crossing them with PD-1 knockout mice. PD-L1 may be a potential therapeutic target in several genetic diseases of immune deficiency affecting cytokine signaling.
- Published
- 2017
- Full Text
- View/download PDF
37. CD4 T cells are rapidly depleted from tuberculosis granulomas following acute SIV co-infection.
- Author
-
Foreman, Taylor W., Nelson, Christine E., Kauffman, Keith D., Lora, Nickiana E., Vinhaes, Caian L., Dorosky, Danielle E., Sakai, Shunsuke, Gomez, Felipe, Fleegle, Joel D., Parham, Melanie, Perera, Shehan R., Lindestam Arlehamn, Cecilia S., Sette, Alessandro, Brenchley, Jason M., Queiroz, Artur T.L., Andrade, Bruno B., Kabat, Juraj, Via, Laura E., and Barber, Daniel L.
- Abstract
HIV /Mycobacterium tuberculosis (Mtb) co-infected individuals have an increased risk of tuberculosis prior to loss of peripheral CD4 T cells, raising the possibility that HIV co-infection leads to CD4 T cell depletion in lung tissue before it is evident in blood. Here, we use rhesus macaques to study the early effects of simian immunodeficiency virus (SIV) co-infection on pulmonary granulomas. Two weeks after SIV inoculation of Mtb-infected macaques, Mtb-specific CD4 T cells are dramatically depleted from granulomas, before CD4 T cell loss in blood, airways, and lymph nodes, or increases in bacterial loads or radiographic evidence of disease. Spatially, CD4 T cells are preferentially depleted from the granuloma core and cuff relative to B cell-rich regions. Moreover, live imaging of granuloma explants show that intralesional CD4 T cell motility is reduced after SIV co-infection. Thus, granuloma CD4 T cells may be decimated before many co-infected individuals experience the first symptoms of acute HIV infection. [Display omitted] • SIV rapidly replicates in Mtb granulomas of co-infected macaques • Granuloma CD4 T cells are depleted before those in blood, BAL, LNs, or spleen • CCR5
+ Eomes− Mtb-specific Th1 and Th1∗ cells in granulomas are preferentially depleted • SIV co-infection reduces motility of CD4 T cells in granulomas HIV-mediated destruction of CD4 T cells enhances susceptibility to Mycobacterium tuberculosis. Using macaques, Foreman et al. show that CD4 T cells in granulomas are depleted very rapidly after SIV co-infection, indicating that loss of immunity at the site of bacterial replication occurs long before signs of peripheral T cell depletion. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
38. Mycobacterial Antigen Driven Activation of CD14++CD16− Monocytes Is a Predictor of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
- Author
-
Andrade, Bruno B., Singh, Amrit, Narendran, Gopalan, Schechter, Melissa E., Nayak, Kaustuv, Subramanian, Sudha, Anbalagan, Selvaraj, Jensen, Stig M. R., Porter, Brian O., Antonelli, Lis R., Wilkinson, Katalin A., Wilkinson, Robert J., Meintjes, Graeme, van der Plas, Helen, Follmann, Dean, Barber, Daniel L., Swaminathan, Soumya, Sher, Alan, and Sereti, Irini
- Subjects
IMMUNE reconstitution inflammatory syndrome ,ANTIGENS ,TUBERCULOSIS treatment ,ANTIRETROVIRAL agents ,CD antigens ,MONOCYTES ,THERAPEUTICS - Abstract
Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) is an aberrant inflammatory response occurring in a subset of TB-HIV co-infected patients initiating anti-retroviral therapy (ART). Here, we examined monocyte activation by prospectively quantitating pro-inflammatory plasma markers and monocyte subsets in TB-HIV co-infected patients from a South Indian cohort at baseline and following ART initiation at the time of IRIS, or at equivalent time points in non-IRIS controls. Pro-inflammatory biomarkers of innate and myeloid cell activation were increased in plasma of IRIS patients pre-ART and at the time of IRIS; this association was confirmed in a second cohort in South Africa. Increased expression of these markers correlated with elevated antigen load as measured by higher sputum culture grade and shorter duration of anti-TB therapy. Phenotypic analysis revealed the frequency of CD14
++ CD16− monocytes was an independent predictor of TB-IRIS, and was closely associated with plasma levels of CRP, TNF, IL-6 and tissue factor during IRIS. In addition, production of inflammatory cytokines by monocytes was higher in IRIS patients compared to controls pre-ART. These data point to a major role of mycobacterial antigen load and myeloid cell hyperactivation in the pathogenesis of TB-IRIS, and implicate monocytes and monocyte-derived cytokines as potential targets for TB-IRIS prevention or treatment. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
39. Role of IL-6 in Mycobacterium avium-Associated Immune Reconstitution Inflammatory Syndrome.
- Author
-
Barber, Daniel L., Andrade, Bruno B., McBerry, Cortez, Sereti, Irini, and Sher, Alan
- Subjects
- *
IMMUNE reconstitution inflammatory syndrome , *ANTIRETROVIRAL agents , *HIV infections , *THERAPEUTICS , *HIV-positive persons , *T cells - Abstract
Immune reconstitution inflammatory syndrome (IRIS) is a major adverse event of antiretroviral therapy in HIV infection, and paradoxically occurs as HIV viremia is suppressed and CD4 T cell numbers recover. IRIS reflects pathogenic immune responses against opportunistic infections acquired during the period of immunodeficiency, but little is understood about the mechanisms of inflammatory pathology. In this study, we show that IL-6 and C-reactive protein levels transiently rise at the time of the IRIS event in HIV-infected patients, umasking Mycobacterium avium complex infection after starting antiretroviral therapy. To directly test the role of IL-6 in IRIS pathology, we used a model of experimentally inducible IRIS in which M. avium-infected T cell-deficient mice undergo a fatal inflammatory disease after reconstitution with CD4 T cells. We find that IL-6 neutralization reduces C-reactive protein levels, alleviates wasting disease, and extends host survival during experimental IRIS. Moreover, we show that combined blockade of IL-6 and IFN-γ further reduces IRIS pathology, even after the onset of wasting disease. The combination of these clinical and experimental-model data show that the IL-6 pathway is not only a biomarker of mycobacterial IRIS but also a major mediator of pathology distinct from IFN-γ and may be a useful target for therapeutic intervention. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
40. Cord Factor and Peptidoglycan Recapitulate the Th17-Promoting Adjuvant Activity of Mycobacteria through Mincle/CARD9 Signaling and the Inflammasome.
- Author
-
Shenderov, Kevin, Barber, Daniel L., Mayer-Barber, Katrin D., Gurcha, Sudagar S., Jankovic, Dragana, Feng, Carl G., Oland, Sandy, Hieny, Sara, Caspar, Pat, Sho Yamasaki, Xin Lin, Ting, Jenny P. -Y., Trinchieri, Giorgio, Besra, Gurdyal S., Cerundolo, Vincenzo, and Sher, Alan
- Subjects
- *
T helper cells , *PEPTIDOGLYCANS , *TREHALOSE dimycolate , *MYCOBACTERIA , *CASPASES , *INFLAMMATION , *IMMUNOREGULATION - Abstract
Although adjuvants are critical vaccine components, their modes of action are poorly understood. In this study, we investigated the mechanisms by which the heat-killed mycobacteria in CFA promote Th17 CD4+ T cell responses. We found that IL-17 secretion by CD4+ T cells following CFA immunization requires MyD88 and IL-1β/IL-1R signaling. Through measurement of Ag-specific responses after adoptive transfer of OTII cells, we confirmed that MyD88-dependent signaling controls Th17 differentiation rather than simply production of IL-17. Additional experiments showed that CFA-induced Th17 differentiation involves IL-1β processing by the inflammasome, as mice lacking caspase-1, ASC, or NLRP3 exhibit partially defective responses after immunization. Biochemical fractionation studies further revealed that peptidoglycan is the major component of heat-killed mycobacteria responsible for inflammasome activation. By assaying Il1b transcripts in the injection site skin of CFA-immunized mice, we found that signaling through the adaptor molecule caspase activation and recruitment domain 9 (CARD9) plays a major role in triggering pro-IL-1β expression. Moreover, we demonstrated that recognition of the mycobacterial glycolipid trehalose dimycolate (cord factor) by the C-type lectin receptor mincle partially explains this CARD9 requirement. Importantly, purified peptidoglycan and cord factor administered in mineral oil synergized to recapitulate the Th17-promoting activity of CFA, and, as expected, this response was diminished in caspase-1- and CARD9-deficient mice. Taken together, these findings suggest a general strategy for the rational design of Th17-skewing adjuvants by combining agonists of the CARD9 pathway with inflammasome activators. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
41. Plasma Heme Oxygenase-1 Levels Distinguish Latent or Successfully Treated Human Tuberculosis from Active Disease
- Author
-
Andrade, Bruno B., Pavan Kumar, Nathella, Mayer-Barber, Katrin D., Barber, Daniel L., Sridhar, Rathinam, Rekha, Vaithilingam V. Banu, Jawahar, Mohideen S., Nutman, Thomas B., Sher, Alan, and Babu, Subash
- Subjects
HEME oxygenase ,TUBERCULOSIS treatment ,OXIDATIVE stress ,ANTIOXIDANTS ,CYTOPROTECTION ,MYCOBACTERIAL diseases ,GENE expression - Abstract
Background: Tuberculosis (TB) is associated with oxidative stress and the induction of host anti-oxidants to counteract this response. Heme oxygenase-1 (HO-1) is a critical promoter of cytoprotection in diverse disease models including mycobacterial infection. Nevertheless, the pattern of expression of HO-1 in human tuberculosis has not been studied. Here, we examine expression of HO-1 in M. tuberculosis-exposed and -infected individuals and test its ability to distinguish active from latent and successfully treated TB cases. In addition, we assess correlations between plasma levels of HO-1 and cytokines closely associated with the immunopathogenesis of TB. Methods: Cross-sectional and longitudinal analyses of levels of HO-1, acute phase proteins and pro-inflammatory cytokines were performed in plasma samples from individuals with active pulmonary, extra-pulmonary or latent TB infection and healthy controls as part of a prospective cohort study in South India. Results: Systemic levels of HO-1 were dramatically increased in individuals with active pulmonary and extra-pulmonary tuberculosis and particularly those with bilateral lung lesions and elevated bacillary loads in sputum. HO-1 levels effectively discriminated active from latent tuberculosis with higher predictive values than either C-reactive protein or serum amyloid protein. Moreover, there was a marked reduction in HO-1 levels in active TB cases following anti-tuberculous therapy but not in those who failed treatment. Pulmonary TB patients displaying the highest concentrations of HO-1 in plasma exhibited significantly elevated plasma levels of interleukin (IL)-10, interferon (IFN)-γ and IL-17 and diminished levels of tumor necrosis factor (TNF)-α. Conclusion: These findings establish HO-1 levels as a potentially useful parameter for distinguishing active from latent or treated pulmonary tuberculosis, that is superior in this respect to the measurement of other acute inflammatory proteins. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
42. CD4 T Cells Promote Rather than Control Tuberculosis in the Absence of PD-1-Mediated Inhibition.
- Author
-
Barber, Daniel L., Mayer-Barber, Katrin D., Feng, Carl G., Sharpe, Arlene H., and Sher, Alan
- Subjects
- *
CD4 antigen , *MYCOBACTERIUM tuberculosis , *T cells , *DISEASE exacerbation , *LABORATORY mice , *DISEASE susceptibility , *CELL receptors , *PREVENTION - Abstract
Although CD4 T cells are required for host resistance to Mycobacterium tuberculosis, they may also contribute to pathology. In this study, we examine the role of the inhibitory receptor PD-1 and its ligand PD-L1 during M. tuberculosis infection. After aerosol exposure, PD-1 knockout (KO) mice develop high numbers of M. tuberculosis-specific CD4 T cells but display markedly increased susceptibility to infection. Importantly, we show that CD4 T cells themselves drive the increased bacterial loads and pathology seen in infected PD-1 KO mice, and PD-1 deficiency in CD4 T cells is sufficient to trigger early mortality. PD-L1 KO mice also display enhanced albeit less severe susceptibility, indicating that T cells are regulated by multiple PD ligands during M. tuberculosis infection. M. tuberculosis-specific CD8 T cell responses were normal in PD-1 KO mice, and CD8 T cells only had a minor contribution to the exacerbated disease in the M. tuberculosis-infected PD-1 KO and PD-L1 KO mice. Thus, in the absence of the PD-1 pathway, M. tuberculosis benefits from CD4 T cell responses, and host resistance requires inhibition by PD-1 to prevent T cell-driven exacerbation of the infection. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
43. Killing of Targets by CD8+ T Cells in the Mouse Spleen Follows the Law of Mass Action.
- Author
-
Ganusov, Vitaly V., Barber, Daniel L., and De Boer, Rob J.
- Subjects
- *
VIRUS diseases , *T cells , *SPLEEN , *LYMPHOCYTIC choriomeningitis virus , *PEPTIDES , *INFECTION , *ARENAVIRUSES , *EPITOPES , *LABORATORY mice - Abstract
It has been difficult to correlate the quality of T cell responses with protection against viral infections. To investigate the relationship between efficacy and magnitude of T cell responses, we quantify the rate at which individual CD8+ effector and memory T cells kill target cells in the mouse spleen. Using mathematical modeling, we analyze recent data on the loss of target cells pulsed with three different peptides from the mouse lymphocytic choriomeningitis virus (LCMV) in mouse spleens with varying numbers of epitope-specific CD8+ T cells. We find that the killing of targets follows the law of massaction, i.e., the death rate of individual target cells remains proportional to the frequency (or the total number) of specific CD8+ T cells in the spleen despite the fact that effector cell densities and effector to target ratios vary about a 1000-fold. The killing rate of LCMV-specific CD8+ T cells is largely independent of T cell specificity and differentiation stage. Our results thus allow one to calculate the critical T cell concentration at which growth of a virus with a given replication rate can be prevented from the start of infection by memory CD8+ T cell response. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
44. Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection.
- Author
-
Vezys, Vaiva, Masopust, David, Kemball, Christopher C., Barber, Daniel L., O'Mara, Leigh A., Larsen, Christian P., Pearson, Thomas C., Ahmed, Raft, and Lukacher, Aron E.
- Subjects
BACTERIA ,CD antigens ,T cells ,PHENOTYPES ,ANTIGENS ,CELL populations - Abstract
Numerous microbes establish persistent infections, accompanied by antigen-specific CD8 T cell activation. Pathogen-specific T cells in chronically infected hosts are often phenotypitally and functionally variable, as well as distinct from T cells responding to nonpersistent infections; this phenotypic heterogeneity has been attributed to an ongoing reencounter with antigen. Paradoxically, maintenance of memory CD8 T cells to acutely resolved infections is antigen independent, whereas there is a dependence on antigen for T cell survival in chronically infected hosts. Using two chronic viral infections, we demonstrate that new naive antigen-specific CD8 T cells are primed after the acute phase of infection. These newly recruited T cells are phenotypically distinct from those primed earlier. Long-lived antiviral CD8 T cells are defective in self-renewal, and lack of thymic output results in the decline of virus-specific CD8 T cells, indicating that newly generated T cells preserve antiviral CD8 T cell populations during chronic infection. These findings reveal a novel role for antigen in maintaining virus-specific CD8 T cells during persistent infection and provide insight toward understanding T cell differentiation in chronic infection. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
45. Biallelic expression of the IL?2 locus under optimal stimulation conditions.
- Author
-
Chiodetti, Lynda, Barber, Daniel L., and Schwartz, Ronald H.
- Published
- 2000
- Full Text
- View/download PDF
46. Anti-CTLA-4 treatment suppresses hepatocellular carcinoma growth through Th1-mediated cell cycle arrest and apoptosis.
- Author
-
Morihara, Hitomi, Yamada, Tomomi, Tona, Yumi, Akasaka, Marina, Okuyama, Hirohisa, Chatani, Natsumi, Shinonome, Satomi, Ueyama, Azumi, Kuwabara, Kenji, and Fujio, Yasushi
- Subjects
MAJOR histocompatibility complex ,IMMUNE checkpoint proteins ,CANCER cells ,HEPATOCELLULAR carcinoma ,TUMOR growth - Abstract
Inhibiting the cytotoxic T-lymphocyte-associated protein-4 (CTLA-4)-mediated immune checkpoint system using an anti-CTLA-4 antibody (Ab) can suppress the growth of various cancers, but the detailed mechanisms are unclear. In this study, we established a monoclonal hepatocellular carcinoma cell line (Hepa1-6 #12) and analyzed the mechanisms associated with anti-CTLA-4 Ab treatment. Depletion of CD4
+ T cells, but not CD8+ T cells, prevented anti-CTLA-4 Ab-mediated anti-tumor effects, suggesting dependence on CD4+ T cells. Anti-CTLA-4 Ab treatment resulted in recruitment of interferon-gamma (IFN-g)-producing CD4+ T cells, called T-helper 1 (Th1), into tumors, and neutralization of IFN-g abrogated the anti-tumor effects. Moreover, tumor growth suppression did not require major histocompatibility complex (MHC)-I or MHC-II expression on cancer cells. In vitro studies showed that IFN-g can induce cell cycle arrest and apoptosis in tumor cells. Taken together, these data demonstrate that anti-CTLA-4 Ab can exert its anti-tumor effects through Th1-mediated cell cycle arrest and apoptosis. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
47. The Helper T Cell’s Dilemma in Tuberculosis.
- Author
-
Barber, Daniel L.
- Abstract
Vaccination approaches eliciting strong CD4 T cell responses provide only weak protection from tuberculosis. In this issue of Cell Host & Microbe , Moguche et al. (2017) show that T cells specific for different immunodominant vaccine antigens can fail to protect for opposite reasons, highlighting a major challenge in tuberculosis vaccine design. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
48. Tuberculosis following PD-1 blockade for cancer immunotherapy.
- Author
-
Barber, Daniel L., Sakai, Shunsuke, Kudchadkar, Ragini R., Fling, Steven P., Day, Tracey A., Vergara, Julie A., Ashkin, David, Cheng, Jonathan H., Lundgren, Lisa M., Raabe, Vanessa N., Kraft, Colleen S., Nieva, Jorge J., Cheever, Martin A., Nghiem, Paul T., and Sharon, Elad
- Subjects
TUBERCULOSIS ,CANCER immunotherapy ,PROGRAMMED cell death 1 receptors ,T cells ,FLOW cytometry ,COMPUTED tomography - Abstract
Increased Mtb-specific T
H 1 responses precede tuberculosis associated with PD-1 blockade. Preaching caution with PD-1 blockade for TB: Scientists are interested in leveraging PD-1 blockade for diseases other than cancer, such as tuberculosis (TB). Barber et al. studied two patients with cancer who developed active TB during PD-1 blockade. Analysis of longitudinal samples available from one of the patients revealed the presence of TB-specific TH 1 cells before presentation of TB. These results are in line with previous work in mouse TB models, which showed that PD-1 deficiency exacerbated disease. This report indicates that PD-1 blockade for treating tuberculosis in humans may instead worsen the disease. Because of the well-established therapeutic benefit of boosting antitumor responses through blockade of the T cell inhibitory receptor PD-1, it has been proposed that PD-1 blockade could also be useful in infectious disease settings, including Mycobacterium tuberculosis (Mtb) infection. However, in preclinical models, Mtb-infected PD-1−/− mice mount exaggerated TH 1 responses that drive lethal immunopathology. Multiple cases of tuberculosis during PD-1 blockade have been observed in patients with cancer, but in humans little is understood about Mtb-specific immune responses during checkpoint blockade–associated tuberculosis. Here, we report two more cases. We describe a patient who succumbed to disseminated tuberculosis after PD-1 blockade for treatment of nasopharyngeal carcinoma, and we examine Mtb-specific immune responses in a patient with Merkel cell carcinoma who developed checkpoint blockade–associated tuberculosis and was successfully treated for the infection. After anti–PD-1 administration, interferon-γ–producing Mtb-specific CD4 T cells became more prevalent in the blood, and a tuberculoma developed a few months thereafter. Mtb-specific TH 17 cells, CD8 T cells, regulatory T cells, and antibody abundance did not change before the appearance of the granuloma. These results are consistent with the murine model data and suggest that boosting TH 1 function with PD-1 blockade may increase the risk or severity of tuberculosis in humans. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
49. Cutting Edge: Expression of FcγRIIB Tempers Memory CD8 T Cell Function In Vivo.
- Author
-
Starbeck-Miller, Gabriel R., Badovinac, Vladimir P., Barber, Daniel L., and Harty, John T.
- Subjects
- *
T cells , *B cells , *CD8 antigen , *GENETICS of virus diseases , *CELL-mediated cytotoxicity - Abstract
During reinfection, high-affinity IgG Abs form complexes with both soluble Ag and Ag displayed on the surface of infected cells. These interactions regulate cellular activation of both innate cells and B cells, which express specific combinations of activating FcγRs (FcγRI, FcγRIII, FcγRIV) and/or the inhibitory FcγR (FcγRIIB). Direct proof for functional expression of FcγR by Ag-specific CD8 T cells is lacking. In this article, we show that the majority of memory CD8 T cells generated by bacterial or viral infection express only FcγRIIB, and that FcγRIIB could be detected on previously activated human CD8 T cells. Of note, FcγR stimulation during in vivo Ag challenge not only inhibited the cytotoxicity of memory CD8 T cells against peptide-loaded or virus-infected targets, but FcγRIIB blockade during homologous virus challenge enhanced the secondary CD8 T cell response. Thus, memory CD8 T cells intrinsically express a functional FcγRIIB, permitting Ag-Ab complexes to regulate secondary CD8 T cell responses. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
50. 4-1BB Signaling Synergizes with Programmed Death Ligand 1 Blockade To Augment CD8 T Cell Responses during Chronic Viral Infection.
- Author
-
Vezys, Vaiva, Penaloza-MacMaster, Pablo, Barber, Daniel L., Sang-Jun Ha, Konieczny, Bogumila, Freeman, Gordon J., Mittler, Robert S., and Ahmed, Raft
- Subjects
- *
INFECTION , *T cells , *LYMPHOCYTIC choriomeningitis , *CELL death , *APOPTOSIS - Abstract
Previous studies have identified the inhibitory role that the programmed death 1 (PD-1) pathway plays during chronic infection. Blockade of this pathway results in rescue of viral-specific CD8 T cells, as well as reduction of viral loads in mice chronically infected with lymphocytic choriomeningitis virus (LCMV). We tested the effect of combining PD ligand 1 (PD-L1) blockade with an agonistic regimen that induces 4-1BB costimulation during chronic LCMV infection. There is a boosting effect in the rescue of LCMV-specific CD8 T cell responses after dual treatment with PD-L1 blockade and 4-1BB agonistic Abs when the amount and timing of 4-1BB costimulation are carefully controlled. When PD-L1--blocking Abs are given together with a single low dose of anti--4-1BB agonistic Abs, there is an enhanced and stable expansion of viral-specific CD8 T cells. Conversely, when blocking Abs to PD-L1 are given with a repetitive high dose of anti--4-1BB, there is an initial synergistic expansion of viral-specific CD8 T cells by day 7, followed by dramatic apoptosis by day 14. Viral control paralleled CD8 T cell kinetics after dual treatment. By day 7 posttreatment, viral titers were lower in both of the combined regimens (compared with PD-L1 blockade alone). However, whereas the high dose of anti--4-1BB plus PD-L1 blockade resulted in rebound of viral titers to original levels, the low dose of anti-4--1BB plus PD-L1 blockade resulted in a stable reduction of viral loads. These findings demonstrate the importance of carefully manipulating the balance between activating and inhibitory signals to enhance T cell responses during chronic infection. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.